Genmab A/S (FRA:GE9)
272.60
-2.80 (-1.02%)
At close: Jan 30, 2026
Genmab Revenue
Genmab had revenue of $1.02B USD in the quarter ending September 30, 2025, with 23.34% growth. This brings the company's revenue in the last twelve months to $3.85B, up 29.57% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.
Revenue (ttm)
$3.85B
Revenue Growth
+29.57%
P/S Ratio
5.09
Revenue / Employee
$1.43M
Employees
2,681
Market Cap
16.68B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.99B | 545.24M | 22.32% |
| Dec 31, 2023 | 2.44B | 358.99M | 17.23% |
| Dec 31, 2022 | 2.08B | 796.62M | 61.88% |
| Dec 31, 2021 | 1.29B | -374.23M | -22.52% |
| Dec 31, 2020 | 1.66B | 855.79M | 106.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Genmab News
- 2 days ago - Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance - Seeking Alpha
- 2 days ago - Grant of Restricted Stock Units and Warrants to Employees in Genmab - GlobeNewsWire
- 3 days ago - Interim Results for the six months ended 31 October 2025 - Benzinga
- 8 days ago - Genmab: Darzalex Growth Fuels Rally, Upside Is Tight - Seeking Alpha
- 10 days ago - Independence Bank of Kentucky Buys 34 Shares of Genmab AS (GMAB) - GuruFocus
- 10 days ago - Genmab Announces 23% Annual Increase In 2025 DARZALEX Sales - Nasdaq
- 11 days ago - Genmab A/S: Genmab Announces Net Sales of DARZALEX (daratumumab) for 2025 - Finanz Nachrichten
- 11 days ago - Genmab Announces Net Sales of DARZALEX (daratumumab) for 2025 - Wallstreet:Online